高强度间歇训练、中等强度持续训练或指南体力活动建议对射血分数保留心力衰竭患者峰值耗氧量的影响:一项随机临床试验
该多中心随机临床试验纳入180例慢性稳定HFpEF久坐患者,比较高强度间歇训练、中等强度持续训练与指南体力活动建议对3个月峰值耗氧量变化的影响。结果显示,高强度间歇训练与中等强度持续训练之间无统计学显著差异,且两组均未达到预设的最小临床重要差异;12个月时无比较达统计学显著。
要点
- HFpEF患者中,高强度间歇训练与中等强度持续训练对3个月峰值耗氧量变化无显著差异。
- 两种训练模式均未达到预设的2.5 mL/kg/min最小临床重要差异。
- 12个月时各比较均无统计学显著性,舒张功能及利钠肽无显著变化。
核心结论
- 在HFpEF患者中,高强度间歇训练与中等强度持续训练对3个月峰值耗氧量变化无统计学显著差异。
- 两种训练模式与指南体力活动建议相比均未达到预设的最小临床重要差异。
- 12个月时各比较均无统计学显著性。
研究设计与样本
- 多中心随机临床试验,2014年7月至2018年9月在德国柏林、莱比锡、慕尼黑,比利时安特卫普和挪威特隆赫姆5个中心开展。
- 从532例筛查患者中纳入180例慢性稳定HFpEF久坐患者,按1:1:1随机分为高强度间歇训练、中等强度持续训练或指南对照组,每组60例。
- 干预12个月(3个月临床期后9个月远程医疗监督的家庭运动),主要终点为3个月峰值耗氧量变化。
主要发现
- 3个月峰值耗氧量变化:高强度间歇训练组1.1 vs 指南对照组-0.6 mL/kg/min(差异1.5,95%CI 0.4至2.7)。
- 3个月峰值耗氧量变化:中等强度持续训练组1.6 vs 指南对照组-0.6 mL/kg/min(差异2.0,95%CI 0.9至3.1)。
- 3个月峰值耗氧量变化:高强度间歇训练组1.1 vs 中等强度持续训练组1.6 mL/kg/min(差异-0.4,95%CI -1.4至0.6)。
- 12个月时各比较均无统计学显著性,舒张功能及利钠肽无显著变化。
- 急性冠脉综合征:高强度间歇训练组4例(7%),中等强度持续训练组3例(5%),指南对照组5例(8%)。
关键数值与推荐
- 主要终点为3个月峰值耗氧量变化,预设最小临床重要差异为2.5 mL/kg/min。
- 高强度间歇训练方案:每周3次,每次38分钟;中等强度持续训练方案:每周5次,每次40分钟;指南对照组接受一次性指南体力活动建议。
临床怎么用
- 对于HFpEF患者,高强度间歇训练或中等强度持续训练相较于指南体力活动建议未显示额外获益。
- 研究结果不支持在HFpEF患者中常规采用高强度间歇训练或中等强度持续训练替代指南体力活动建议。
局限性
- 患者和评估人员未设盲,仅核心实验室对治疗分组设盲。
- 12个月时失访导致完成评估的患者数减少(3个月166例,12个月154例)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Endurance exercise is effective in improving peak oxygen consumption (peak V̇o2) in patients with heart failure with preserved ejection fraction (HFpEF). However, it remains unknown whether differing modes of exercise have different effects. OBJECTIVE: To determine whether high-intensity interval training, moderate continuous training, and guideline-based advice on physical activity have different effects on change in peak V̇o2 in patients with HFpEF. DESIGN, SETTING, AND PARTICIPANTS: Randomized clinical trial at 5 sites (Berlin, Leipzig, and Munich, Germany; Antwerp, Belgium; and Trondheim, Norway) from July 2014 to September 2018. From 532 screened patients, 180 sedentary patients with chronic, stable HFpEF were enrolled. Outcomes were analyzed by core laboratories blinded to treatment groups; however, the patients and staff conducting the evaluations were not blinded. INTERVENTIONS: Patients were randomly assigned (1:1:1; n = 60 per group) to high-intensity interval training (3 × 38 minutes/week), moderate continuous training (5 × 40 minutes/week), or guideline control (1-time advice on physical activity according to guidelines) for 12 months (3 months in clinic followed by 9 months telemedically supervised home-based exercise). MAIN OUTCOMES AND MEASURES: Primary end point was change in peak V̇o2 after 3 months, with the minimal clinically important difference set at 2.5 mL/kg/min. Secondary end points included changes in metrics of cardiorespiratory fitness, diastolic function, and natriuretic peptides after 3 and 12 months. RESULTS: Among 180 patients who were randomized (mean age, 70 years; 120 women [67%]), 166 (92%) and 154 (86%) completed evaluation at 3 and 12 months, respectively. Change in peak V̇o2 over 3 months for high-intensity interval training vs guideline control was 1.1 vs -0.6 mL/kg/min (difference, 1.5 [95% CI, 0.4 to 2.7]); for moderate continuous training vs guideline control, 1.6 vs -0.6 mL/kg/min (difference, 2.0 [95% CI, 0.9 to 3.1]); and for high-intensity interval training vs moderate continuous training, 1.1 vs 1.6 mL/kg/min (difference, -0.4 [95% CI, -1.4 to 0.6]). No comparisons were statistically significant after 12 months. There were no significant changes in diastolic function or natriuretic peptides. Acute coronary syndrome was recorded in 4 high-intensity interval training patients (7%), 3 moderate continuous training patients (5%), and 5 guideline control patients (8%). CONCLUSIONS AND RELEVANCE: Among patients with HFpEF, there was no statistically significant difference in change in peak V̇o2 at 3 months between those assigned to high-intensity interval vs moderate continuous training, and neither group met the prespecified minimal clinically important difference compared with the guideline control. These findings do not support either high-intensity interval training or moderate continuous training compared with guideline-based physical activity for patients with HFpEF. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02078947.
引用
- Mueller S, Winzer EB, Duvinage A, et al. Effect of High-Intensity Interval Training, Moderate Continuous Training, or Guideline-Based Physical Activity Advice on Peak Oxygen Consumption in Patients With Heart Failure With Preserved Ejection Fraction: A Randomized Clinical Trial. JAMA. 2021. PMID: 33560320. doi:10.1001/jama.2020.26812
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。